- Home
- SAVA vs GRO Comparison
SAVA vs GRO Comparison
Compare SAVA & GRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- GRO
- Stock Information
- Founded
- SAVA 1998
- GRO 2006
- Country
- SAVA United States
- GRO Canada
- Employees
- SAVA N/A
- GRO N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- GRO
- Sector
- SAVA Health Care
- GRO
- Exchange
- SAVA Nasdaq
- GRO NYSE
- Market Cap
- SAVA 70.5M
- GRO 58.0M
- IPO Year
- SAVA N/A
- GRO 2024
- Fundamental
- Price
- SAVA $2.35
- GRO $1.82
- Analyst Decision
- SAVA Buy
- GRO Strong Buy
- Analyst Count
- SAVA 2
- GRO 1
- Target Price
- SAVA $54.50
- GRO $5.50
- AVG Volume (30 Days)
- SAVA 1.2M
- GRO 2.9M
- Earning Date
- SAVA 08-07-2025
- GRO 08-05-2025
- Dividend Yield
- SAVA N/A
- GRO N/A
- EPS Growth
- SAVA N/A
- GRO N/A
- EPS
- SAVA N/A
- GRO N/A
- Revenue
- SAVA N/A
- GRO N/A
- Revenue This Year
- SAVA N/A
- GRO N/A
- Revenue Next Year
- SAVA N/A
- GRO N/A
- P/E Ratio
- SAVA N/A
- GRO N/A
- Revenue Growth
- SAVA N/A
- GRO N/A
- 52 Week Low
- SAVA $1.15
- GRO $1.25
- 52 Week High
- SAVA $42.20
- GRO $15.00
- Technical
- Relative Strength Index (RSI)
- SAVA 56.89
- GRO N/A
- Support Level
- SAVA $2.11
- GRO N/A
- Resistance Level
- SAVA $2.72
- GRO N/A
- Average True Range (ATR)
- SAVA 0.16
- GRO 0.00
- MACD
- SAVA 0.04
- GRO 0.00
- Stochastic Oscillator
- SAVA 52.56
- GRO 0.00
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About GRO BRAZIL POTASH CORP
Brazil Potash Corp is a mineral exploration and development company with a potash mining project located in the state of Amazonas, Brazil. The company's technical operations are based in Autazes, Amazonas, Brazil, and Belo Horizonte, Minas Gerais, Brazil. The operating activities of the company include focusing on the extraction and processing of potash ore from the underground mine of the Autazes Project and selling and distributing the processed potash in Brazil.